TABLE 2

Metabolite Ratios in Prostate Hyperplasia and Prostate Carcinoma (112,113)

Mean ± SD (range) for the following ratio:
PatientsCitrate-to-cholineCreatine-to-cholineCreatine-to-myoinositol
Prostate hyperplasia3.01 ± 0.86 (2.09–5.04)0.49 ± 0.07 (0.35–0.59)1.41 ± 0.48 (1.02–2.77)
Prostate cancer0.39 ± 0.28 (0–0.78)0.21 ± 0.14 (0–0.4)0.63 ± 0.31 (0–0.96)